CapWealth Advisors LLC Sells 7,924 Shares of CVS Health Corporation $CVS

CapWealth Advisors LLC cut its stake in shares of CVS Health Corporation (NYSE:CVS) by 2.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 318,909 shares of the pharmacy operator’s stock after selling 7,924 shares during the quarter. CVS Health makes up approximately 2.2% of CapWealth Advisors LLC’s holdings, making the stock its 19th biggest position. CapWealth Advisors LLC’s holdings in CVS Health were worth $24,043,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CVS. Cantor Fitzgerald Investment Advisors L.P. grew its position in shares of CVS Health by 1.6% during the second quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock worth $28,264,000 after purchasing an additional 6,615 shares in the last quarter. Aaron Wealth Advisors LLC boosted its stake in CVS Health by 177.4% in the 3rd quarter. Aaron Wealth Advisors LLC now owns 34,259 shares of the pharmacy operator’s stock worth $2,583,000 after purchasing an additional 21,911 shares during the period. Red Mountain Financial LLC purchased a new stake in CVS Health during the 2nd quarter valued at approximately $293,000. Osaic Holdings Inc. raised its position in shares of CVS Health by 18.4% during the second quarter. Osaic Holdings Inc. now owns 229,903 shares of the pharmacy operator’s stock valued at $15,828,000 after buying an additional 35,809 shares during the last quarter. Finally, AE Wealth Management LLC lifted its holdings in shares of CVS Health by 607.5% in the second quarter. AE Wealth Management LLC now owns 242,221 shares of the pharmacy operator’s stock worth $16,708,000 after buying an additional 207,984 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Down 0.6%

Shares of CVS opened at $79.35 on Friday. The company has a quick ratio of 0.63, a current ratio of 0.83 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a 52-week low of $43.72 and a 52-week high of $85.15. The company has a market cap of $100.73 billion, a PE ratio of 208.82, a P/E/G ratio of 0.78 and a beta of 0.48. The business has a fifty day moving average of $78.71 and a 200 day moving average of $73.28.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. During the same quarter in the prior year, the firm posted $1.09 earnings per share. The business’s revenue for the quarter was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, sell-side analysts expect that CVS Health Corporation will post 5.89 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a research note on Monday. Royal Bank Of Canada restated an “outperform” rating on shares of CVS Health in a research report on Thursday, December 4th. The Goldman Sachs Group boosted their target price on CVS Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, December 10th. UBS Group restated an “outperform” rating on shares of CVS Health in a report on Wednesday, December 10th. Finally, JPMorgan Chase & Co. lifted their price objective on CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 17th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.67.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.